Alkermes’ Corporate Presentation to be Webcast at the Jefferies 2015 Global Healthcare Conference
Alkermes plc (NASDAQ:ALKS) announced today that its corporate presentation will be webcast live at the Jefferies 2015 Global Healthcare Conference on Monday, June 1, 2015, at 11:30 a.m. EDT (4:30 p.m. BST) from the Grand Hyatt New York. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
Sorry. No data so far.